Lv3
388 积分 2024-02-02 加入
Expert consensus on the application and management of therapeutic drugs for atopic dermatitis （2024）
1个月前
已完结
Psychometric Validity of the Strengths and Difficulties Questionnaire-Dysregulation Profile
1个月前
已完结
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
3个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
5个月前
已完结
[Recommendations for the diagnosis and treatment of rheumatic diseases-related hemophagocytic syndrome in China]
5个月前
已完结
CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients
5个月前
已完结
Classification and definition of major flares in SLE clinical trials
7个月前
已完结
Current challenges and emerging opportunities of CAR-T cell therapies
9个月前
已完结
Cancer-fighting immune cells could soon be engineered inside our bodies
9个月前
已完结
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
10个月前
已完结
皖公网安备34019202002308
